MedTrace Logo

The Effect of Acute Lysine Administration on α-aminoadipic Acid

NCT02756117 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2017-02-07

No results posted yet for this study

Summary

This study aims to assess the effect and breakdown of lysine administration, specifically examining whether it leads to increased plasma 2-AAA in healthy humans.

Conditions

  • Healthy
  • Pre-diabetic

Interventions

DRUG

L-Lysine

DRUG

Normal (0.9%) Saline

Sponsors & Collaborators

  • Vanderbilt University

    lead OTHER

Principal Investigators

  • Jane F Ferguson, PhD · Vanderbilt Cardiovascular Medicine

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2016-10-01
Completion
2016-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02756117 on ClinicalTrials.gov